With 1.0 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.34 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $16.68 whereas the lowest price it dropped to was $13.99. The 52-week range on RGC shows that it touched its highest point at $83.60 and its lowest point at $0.09 during that stretch. Beta for the stock currently stands at 2.14.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RGC was up-trending over the past week, with a rise of 21.66%, but this was up by 5.89% over a month. Three-month performance dropped to -21.64% while six-month performance rose 11847.32%. The stock gained 11653.85% in the past year, while it has gained 7015.69% so far this year.
Float and Shares Shorts:
At present, 494.49 million RGC shares are outstanding with a float of 19.01 million shares on hand for trading. On 2025-08-15, short shares totaled 2.26 million, which was 46.0 higher than short shares on 1752537600. In addition to Mr. Yat-Gai Au as the firm’s Founder, Chairman & CEO, Ms. Michelle Chan serves as its Financial Controller & Principal Financial Officer.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
